CrossRef Text and Data Mining
Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.
Efficacy and safety of a 24-day regimen of drospirenone-containing combined oral contraceptive in Korean women
Nayoung Kim, Ha-Na Yoo, Hye Sun Hyun, Dong-Yun Lee, Byung-Koo Yoon, Doo-Seok Choi
Obstet Gynecol Sci. 2015;58(5):397-400.   Published online September 22, 2015
DOI: https://doi.org/10.5468/ogs.2015.58.5.397

Excel Download

Efficacy and safety of a 24-day regimen of drospirenone-containing combined oral contraceptive in Korean women
Obstetrics & Gynecology Science. 2015;58(5):397   Crossref logo
Link1 Link2 Link3

Efficacy and safety of a low-dose combined oral contraceptive containing drospirenone 3 mg and ethinylestradiol 20 mcg in a 24/4-day regimen
Contraception. 2009;80(1):18-24   Crossref logo
Link1 Link2

Efficacy and safety of drospirenone-containing microdosage combined oral contraceptive use with starting contraception
Gynecology. 2018;20(2):9-13   Crossref logo
Link1 Link2

Cardiovascular and general safety of a 24-day regimen of drospirenone-containing combined oral contraceptives: final results from the International Active Surveillance Study of Women Taking Oral Contraceptives
Contraception. 2014;89(4):253-263   Crossref logo
Link1 Link2

P735 Contraceptive efficacy of a combined oral contraceptive containing ethinylestradiol 20 mcg/drospirenone 3 mg administered in 24/4 regimen: a pooled analysis of four, open-label studies
International Journal of Gynecology & Obstetrics. 2009;107:S622-S622   Crossref logo
Link1 Link2 Link3 Link4 Link5

Efficacy and safety of a low-dose 24-day combined oral contraceptive containing 20 μg ethinylestradiol and 3 mg drospirenone
Contraception. 2004;70(3):191-198   Crossref logo
Link1 Link2

Efficacy and cardiovascular safety of the new estrogen-free contraceptive pill containing 4 mg drospirenone alone in a 24/4 regime. Cardiovascular safety of the new estrogen-free contraceptive pill containing 4 mg drospirenone alone in a 24/4 regime.
. 2020;   Crossref logo
Link1 Link2

Efficacy and cardiovascular safety of the new estrogen-free contraceptive pill containing 4 mg drospirenone alone in a 24/4 regime. Cardiovascular safety of the new estrogen-free contraceptive pill containing 4 mg drospirenone alone in a 24/4 regime.
. 2020;   Crossref logo
Link1 Link2

A 1-year prospective, open-label, single-arm, multicenter, phase 3 trial of the contraceptive efficacy and safety of the oral progestin-only pill drospirenone 4 mg using a 24/4-day regimen
Contraception: X. 2020;2:100020   Crossref logo
Link1 Link2

Long-term efficacy and safety of a monophasic combined oral contraceptive containing 0.02 mg ethinylestradiol and 2 mg chlormadinone acetate administered in a 24/4-day regimen
Contraception. 2010;81(6):501-509   Crossref logo
Link1 Link2